BIOG B — Biogaia AB Income Statement
0.000.00%
Last trade - 00:00- SEK10.57bn
- SEK9.32bn
- SEK1.42bn
- 99
- 26
- 27
- 48
Annual income statement for Biogaia AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 747 | 785 | 1,104 | 1,297 | 1,423 |
| Cost of Revenue | |||||
| Gross Profit | 547 | 583 | 802 | 950 | 1,031 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 519 | 531 | 742 | 853 | 999 |
| Operating Profit | 228 | 254 | 361 | 443 | 423 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 228 | 253 | 448 | 469 | 448 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 180 | 196 | 374 | 365 | 351 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 180 | 196 | 374 | 365 | 351 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 180 | 196 | 374 | 365 | 351 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.01 | 2.08 | 3.74 | 3.65 | 3.9 |
| Dividends per Share |